Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1447]

Meet the Expert: Daniel Seymour

Daniel Seymour - BIO Ventures for Global Health, Seattle, USA

Meet the Expert: Daniel Seymour ( Daniel Seymour - BIO Ventures for Global Health, Seattle, USA )

COMBI-AD trial: Adjuvant dabrafenib plus trametinib in patients with resected...

Prof Axel Hauschild - University Hospital, Schleswig-Holstein, Germany

COMBI-AD trial: Adjuvant dabrafenib plus trametinib in patients with resected stage III BRAF V600–mutant melanoma ( Prof Axel Hauschild - University Hospital, Schleswig-Holstein, Germany )

Medical oncology care amidst the COVID-19 pandemic at the National University...

Dr Marvin Mendoza - University of the Philippines - Philippine General Hospital...

Medical oncology care amidst the COVID-19 pandemic at the National University Hospital in the Philippines ( Dr Marvin Mendoza - University of the Philippines - Philippine General Hospital, Manila, Philippines )

Preclinical models for small-cell lung cancer

Prof Anton Berns - Netherlands Cancer Institute, Amsterdam, Netherlands

Preclinical models for small-cell lung cancer ( Prof Anton Berns - Netherlands Cancer Institute, Amsterdam, Netherlands )

Conducting Oncology Clinical Trials in Africa II: Regulatory Process for...

Mr Dennis Ake, MSc.

Conducting Oncology Clinical Trials in Africa II: Regulatory Process for Clinical Trials in Africa ( Mr Dennis Ake, MSc. )

Pembrolizumab vs brentuximab vedotin in relapsed or refractory classic Hodgkin...

Dr John Kuruvilla - Princess Margaret Cancer Centre, Toronto, Canada

$Pembrolizumab vs brentuximab vedotin in relapsed or refractory classic Hodgkin lymphoma ( Dr John Kuruvilla - Princess Margaret Cancer Centre, Toronto, Canada )$

Perioperative chemotherapy with mFOLFIRINOX vs gemcitabine/nab-paclitaxel for...

Prof Davendra Sohal - University of Cincinnati, Cincinnati, USA

Perioperative chemotherapy with mFOLFIRINOX vs gemcitabine/nab-paclitaxel for resectable pancreatic ductal adenocarcinoma ( Prof Davendra Sohal - University of Cincinnati, Cincinnati, USA )

High-dose twice daily thoracic radiotherapy in limited disease small-cell lung...

Prof Bjørn Henning Grønberg - Trondheim University Hospital, Trondheim, Norway

High-dose twice daily thoracic radiotherapy in limited disease small-cell lung cancer ( Prof Bjørn Henning Grønberg - Trondheim University Hospital, Trondheim, Norway )

Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation...

Prof Thierry Conroy - Institute Cancer De Lorraine, Nancy, France

Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients with locally advanced rectal cancer ( Prof Thierry Conroy - Institute Cancer De Lorraine, Nancy, France )

AGO DESKTOP III/ENGOT-ov20: Impact of secondary cytoreductive surgery in...

Prof Andreas du Bois - Kliniken Essen Mitte, Essen, Germany

AGO DESKTOP III/ENGOT-ov20: Impact of secondary cytoreductive surgery in recurrent ovarian cancer ( Prof Andreas du Bois - Kliniken Essen Mitte, Essen, Germany )

Three versus six months of adjuvant oxaliplatin and fluoropyrimidine-based...

Prof Alberto Sobrero - Ospedale Policlinico San Martino, Genova, Italy

Three versus six months of adjuvant oxaliplatin and fluoropyrimidine-based therapy for patients with stage III colon cancer ( Prof Alberto Sobrero - Ospedale Policlinico San Martino, Genova, Italy )

PARP inhibitors in prostate cancer: Choices of tests and how to test?

Dr Kim Chi and Dr Alexander Wyatt

PARP inhibitors in prostate cancer: Choices of tests and how to test? ( Dr Kim Chi and Dr Alexander Wyatt )

More from ecancer